openPR Logo

Press Releases from Unither Pharmaceuticals (3 total)

Unither Pharmaceuticals has completed the purchase of the Novartis site located …

Paris (France), 12/07/2022 - Unither Pharmaceuticals, the world's leading manufacturer of sterile unit-dose products, recently acquired the Novartis plant in São Paulo, Brazil, as a new step in its industrial expansion in Brazil. « This acquisition enables us to benefit from sterile operations in Latin America and to enlarge our offer to multidose ophthalmic containers. We are pleased to welcome the 180 people joining Unither Pharmaceuticals and bring new possibilities to

Unither Pharmaceuticals initiated the acquisition of Nanjing Ruinian Best Pharma …

Paris (France) and Nanjing (China), August 25th, 2020 – Unither Pharmaceuticals, a global leader in sterile single dose technology, initiated today the acquisition of Nanjing Ruinian Best Pharmaceutical Co. Ltd, a Chinese pharmaceutical company. With this acquisition, Unither is accelerating the development of its business in China, the second largest market in the world, and complementing the worldwide Unither industrial footprint in Europe, the US and Brazil. “We are delighted

New technology acquisition provides Unither Pharmaceuticals with specialized tra …

Preliminary clinical trials have shown that this technology would enable to lower the dosage of paracetamol while keeping the same effect as traditional dosage for oral forms. The deal comes after previous patents acquisitions by Unither Pharmaceuticals in the last years related to oro-dispersible formulations. This addition will further enhance Unither Pharmaceuticals capabilities to deliver innovative solutions through its recently launched ODTechTM platform, offering several solid and liquid stick packs technologies. Unither Pharmaceuticals’

Go To Page:   1